Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Breathing treatment for recovery after spinal cord injury

Official title: Genetic Biomarkers of Intermittent Hypoxia-Induced Respiratory Motor Plasticity in Chronic SCI

Run by University of Florida · NCT06011876 · Data updated 2026-11-12

This study is testing if a new breathing treatment can help people with spinal cord injuries recover their breathing and movement better than a standard treatment.

More Spinal Cord Injuries trials

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment62 (estimated)
SponsorUniversity of Florida
Academic / other
Locations1 site (Jacksonville, Florida)
StatusRecruiting
StartedDecember 21, 2023
Main results expectedJuly 2027
Study endsSeptember 2027
Registry record updatedSeptember 14, 2026
Trial IDNCT06011876 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-70 with chronic incomplete or complete spinal cord injuries lasting at least one year.

Probably not a fit

Patients with progressive spinal cord conditions or those outside the specified age range may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of acute intermittent hypoxia (AIH) and acute intermittent hypercapnic-hypoxia (AIHH) on respiratory function and motor recovery in individuals with spinal cord injuries. Participants will undergo a series of tests and receive one of three interventions: AIH, AIHH, or a sham treatment, followed by assessments to measure changes in breathing and motor function. The study also includes respiratory strength training to enhance the effectiveness of the interventions. The goal is to determine if AIHH provides greater benefits compared to AIH and to explore how genetic variations may influence individual responses to these treatments.

Why it matters

Potential benefit: If successful, this treatment could significantly improve breathing and motor function in patients with spinal cord injuries.

How similar studies have gone: Previous studies have shown promising results with acute intermittent hypoxia approaches, suggesting potential for success in this novel application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adults 18-70 years of age
2. Chronic incomplete SCI ≥ 1 year at or below C1-T12

   * Incomplete SCI based on residual sensory and motor function below the level of the injury or injury classification of B, C, D at initial screening according to the American Spinal Injury Association Impairment Classification and the International Standards for the Neurological Classification of SCI.

   -OR- Chronic complete SCI ≥1 year at or below C4-T12
   * Complete SCI based on the absence of residual sensory or motor function below the level of injury or injury classification of A at initial screening according to the American Spinal Injury Association Impairment Classification and the International Standards for the Neurological Classification of SCI.
3. Medically stable with physician clearance
4. SCI due to non-progressive etiology
5. 20% impairment in maximal inspiratory, maximal expiratory pressure generation, or both relative to normative values

Exclusion Criteria:

1. Current diagnosis of an additional neurologic condition such as Multiple Sclerosis, Parkinson disease, stroke, or brain injury
2. Severe illness or infection, including non-healing decubitus ulcers, untreated bladder or urinary tract infections, cardiovascular disease, lung disease, active heterotopic ossification, or uncontrolled hypertension
3. Severe neuropathic pain
4. Known pregnancy
5. Severe recurrent autonomic dysreflexia

Exclusion for involvement in TMS - History of seizure disorder, uncontrolled migraines, presence of cardiac pacemaker, metal implants in skull, medications that lower seizure threshold.

Where it's running

  • Brooks Rehabilitation
    Jacksonville, Florida, United States
    Recruiting

Study contacts

  • Principal investigator: Emily Fox, DPT, MHS, PhD — University of Florida & Brooks Rehabilitation
  • Study coordinator: Emily J Fox, PT, MHS, PhD
  • Email: ejfox@phhp.ufl.edu
  • Phone: 904-742-2500

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.